Website privacy policy

Novocure recognizes the importance of protecting the privacy of the users of its website. The information about you collected on this website is subject to this policy and the following paragraphs. Novocure may change this policy from time to time, so please revisit this privacy policy to be sure that you are familiar with its current policies.

Collection and Use of Information

Personally Identifiable Information

Novocure collects personally identifiable information (information that can be used to identify an individual) such as name, address, telephone number, email address or other information only when you voluntarily submit it to Novocure, such as when you email a question or request or submit a form for more information. Novocure will use this information to respond to requests for information and may use this information to contact you and provide you with information about our products. Novocure may also request that you provide us with demographic information (such as gender and age) or other information (such as medical condition or treatment information) that Novocure uses to help serve you better.

Non-Personally Identifiable Information

Novocure may also collect non-personally identifiable information (information that does not identify a specific individual) relating to such matters as: the number of visits to the website, the number of visitors to each page of the website, visitors' internet protocol (IP) addresses, and time spent on the website. Novocure uses this information, in aggregate form, to understand how visitors use the website so that Novocure can make improvements. Novocure may also use your IP address to help diagnose problems with servers and for purposes of system administration.


The use of cookies is now industry standard and they are used by most major websites, including Novocure's website. A cookie is a piece of data stored on a user's hard drive containing information about the user. Cookies can also enable Novocure to track the interests of users to enhance their experience on this website, and to deliver content specific to a user's interests. Novocure may place a cookie in the browser file of your computer and use similar technologies to communicate with cookies. You are always free to decline Novocure's cookie, and you may still use the site; however, some parts of the site may not work properly for you.

Information Sharing

Except as otherwise disclosed in this privacy policy, Novocure will not sell, rent, or distribute personally identifiable information we collect to any third party, unless we obtain your permission by at least giving you the opportunity to opt out of any such sharing. We may, however, share your personally identifiable information without permission or further notice with our affiliates, business partners (as described below), or others who work for us such as service providers, vendors, contractors, and agents. To the extent you submit personally identifiable information related to a specific initiative or campaign, we may share the information with any subsequently formed affiliate dedicated to such initiative or campaign. Novocure may share non-personally identifiable information with agents, business partners, consultants or other outside companies.

We may partner with other companies to provide or offer you content or services on a joint or cobranded basis. At a cobranded site or in joint marketing materials, you would likely see both the Novocure logo and the logo of the cobranded partner displayed on your screen. To access the services available on a cobranded site, you may have to complete a new online registration form, and this registration information may be shared with Novocure and Novocure's cobranded partners. You should read the individual privacy policies of our cobranded partners, as these may differ in some respects from ours. Reading these policies will help you to make an informed decision about whether to provide your information to a given site. You may opt out of sharing your information with a partner site by choosing not to use the service or content provided by the cobranded site.

To the extent permitted by law, any personally identifiable information or other information collected over our website or concerning its use, including the content of any communication you submit or post to any interactive features on the website (personally identifiable or not), may be disclosed to government authorities or third parties pursuant to a governmental investigation, legal request, subpoena, or other legal process. We also may share information with the government even without a request pursuant to regulatory reporting requirements. In addition, we may also use or disclose your information as permitted by law to enforce our rights, fight fraud, or protect the rights or property of Novocure, our affiliates, our patients, our website, its users, or third parties, or when we otherwise believe in good faith that the law requires it.

Corporate Change of Control or Sale of Assets

In the event of a corporate change in control resulting from, for example, a sale to or merger with another entity, or in the event of a sale of assets or a bankruptcy, Novocure reserves the right to transfer your personally identifiable information to the new party in control or the party acquiring assets.


Novocure does not knowingly collect any personal information from anyone under the age of 18, nor does Novocure knowingly market its website to anyone under the age of 18.


Please be advised that although Novocure has tried to create a secure and reliable site, the confidentiality of any communication or material transmitted to or from this website cannot be guaranteed. Novocure urges you to always exercise caution when conveying personal information over the internet.

When disclosing any personally identifiable information, you should remain mindful that such information might be accessible by the public and, consequently, may be collected and used by others without your consent. You should also recognize that your use of the internet and this site is solely at your own risk.

Changes to this Privacy Policy

Novocure reserves the right, in its sole discretion, to modify, alter or otherwise update this policy at any time and you agree to be bound by such modifications, alterations, or updates. We will notify you of material changes to this privacy policy by posting the revised policy with the date it was revised on this page. Your continued use of our website constitutes your agreement to this privacy statement and any updates. We encourage you to periodically review this privacy statement to stay informed about how we are using the personally identifiable information we collect.

Questions or Concerns

If you have other questions or concerns about our privacy policies or information usage, or wish to change any choices offered about how your information is handled or shared, email us at

Effective Date: April 7, 2014


What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

What is Optune Lua approved to treat?

Optune Lua is a wearable, portable, FDA-approved device indicated for the treatment of adult patients, with unresectable, locally advanced or metastatic, malignant pleural mesothelioma (MPM) to be used together with standard chemotherapy (pemetrexed and platinum-based chemotherapy).

Who should not use Optune for GBM or Optune Lua for MPM?

Optune for GBM and Optune Lua for MPM are not for everyone. Talk to your doctor if you have:

Do not use Optune for GBM or Optune Lua for MPM if you are pregnant or are planning to become pregnant. It is not known if Optune/Optune Lua is safe or effective during pregnancy.

What should I know before using Optune for GBM or Optune Lua for MPM?

Optune and Optune Lua should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure®, the maker of Optune and Optune Lua.

What are the possible side effects of Optune for GBM and Optune Lua for MPM?

The most common side effects of Optune when used together with chemotherapy for GBM (temozolomide or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, seizure, and depression.

The most common side effects when using Optune alone for GBM were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

The most common side effects of Optune Lua when used together with chemotherapy for MPM (pemetrexed and platinum-based chemotherapy) were low red blood cell count, constipation, nausea, tiredness, chest pain, fatigue, skin irritation from device use, itchy skin, and cough.

Other potential adverse effects associated with the use of Optune Lua include: treatment related skin irritation, allergic reaction to the plaster or to the gel, electrode overheating leading to pain and/or local skin burns, infections at sites of electrode contact with the skin, local warmth and tingling sensation beneath the electrodes, muscle twitching, medical device site reaction and skin breakdown/skin ulcer.

Talk to your doctor if you have any of these side effects or questions.

Caution: Federal law restricts Optune Lua to sale by or on the order of a physician. Humanitarian Device. Authorized by Federal Law for use in the treatment of adult patients with unresectable, locally advanced or metastatic, malignant pleural mesothelioma concurrently with pemetrexed and platinum-based chemotherapy. The effectiveness of this device for this use has not been demonstrated.

Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

Please click here to see the Optune Lua IFU for complete information regarding the device's indications, contraindications, warnings, and precautions.

On this site, patient and healthcare professional videos as well as all images labeled as Optune users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals. All other depictions of patients and caregivers are actor portrayals. Patient images reflect the health status of the patients at the time each photo was taken.

What is Optune approved to treat?

Optune is indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.